Aptar reports Q3 net income $100M (+19%), adjusted EPS $1.49 (+6%)

APTARGROUP, INC.

2024-Q3 EPS reported $4.05 revenue$2,734,802,000

Revenue $909M (+2% core sales); Pharma segment core sales +7%, Beauty -6%, Closures +4%.
Adjusted EBITDA $208M (23% margin); reported EPS $1.48 vs $1.26 prior year.
Q4 2024 adjusted EPS guidance $1.22-$1.30; full year adjusted EPS outlook $5.34-$5.42, double-digit YoY growth.
Quarterly dividend $0.45/share, payable Nov 14 to holders of record Oct 24; Board authorized $500M share repurchase program.
Pharma drug delivery systems grew double digits; Closures margins up ~200 bps YoY.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.